Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Kotb

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical Lymphoma & Myeloma|June 27, 2006
Late clinically silent perforation of intestinal non-Hodgkin's lymphomaRami Kotb, Eric Turcotte, Nathalie McFadden, et al.
Hematological Oncology|April 23, 2013
Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapyTanya Berrang, Caroline Holloway, Jason Hart, et al.
Critical Reviews in Oncogenesis|March 4, 2014
Immunosenescence and cancerTamas Fulop, Anis Larbi, Jacek M Witkowski, et al.
Transfusion|November 16, 2011
Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopeniaMaxime Berthelot-Richer, Brigitte Boilard, Annie Morin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2025
Real-World Safety and Tolerability of Rapid, 30-Minutes, Intravenous Isatuximab in Patients With Multiple MyelomaRami Kotb, Marc Geirnaert, Emily Rimmer, et al.
The Journal of Rheumatology|July 5, 2005
Efficacy of rituximab in refractory polymyositisOlivier Lambotte, Rami Kotb, Gwenola Maigne, et al.
International Journal of Cancer|October 7, 2016
Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myelomaChirawadee Sathitruangsak, Christiaan H Righolt, Ludger Klewes, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Potential role of immunosenescence in cancer developmentTamas Fulop, Rami Kotb, Carl F Fortin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2025
Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in ManitobaKaitlin Quinlan, Marc Geirnaert, Rami Kotb, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline ConsortiumRichard LeBlanc, Debra J Bergstrom, Julie Côté, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical Lymphoma & Myeloma|June 27, 2006
Late clinically silent perforation of intestinal non-Hodgkin's lymphomaRami Kotb, Eric Turcotte, Nathalie McFadden, et al.
Hematological Oncology|April 23, 2013
Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapyTanya Berrang, Caroline Holloway, Jason Hart, et al.
Critical Reviews in Oncogenesis|March 4, 2014
Immunosenescence and cancerTamas Fulop, Anis Larbi, Jacek M Witkowski, et al.
Transfusion|November 16, 2011
Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopeniaMaxime Berthelot-Richer, Brigitte Boilard, Annie Morin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2025
Real-World Safety and Tolerability of Rapid, 30-Minutes, Intravenous Isatuximab in Patients With Multiple MyelomaRami Kotb, Marc Geirnaert, Emily Rimmer, et al.
The Journal of Rheumatology|July 5, 2005
Efficacy of rituximab in refractory polymyositisOlivier Lambotte, Rami Kotb, Gwenola Maigne, et al.
International Journal of Cancer|October 7, 2016
Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myelomaChirawadee Sathitruangsak, Christiaan H Righolt, Ludger Klewes, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Potential role of immunosenescence in cancer developmentTamas Fulop, Rami Kotb, Carl F Fortin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2025
Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in ManitobaKaitlin Quinlan, Marc Geirnaert, Rami Kotb, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline ConsortiumRichard LeBlanc, Debra J Bergstrom, Julie Côté, et al.
Pageof 7